DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Panacea Biotec Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·7 Oct 2026, 10:30 am

Panacea Biotec

Panacea Biotec Limited has informed the stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations, 2018. This document confirms that the company has complied with the regulatory requirements for maintaining its dematerialized (demat) securities.

This compliance is a routine procedural step for listed companies. It ensures that the company's shares are properly held in electronic form and that all regulatory obligations regarding shareholding patterns are met. For investors, this is a standard administrative update rather than a financial event.

Investors should view this as a routine corporate filing. It does not indicate any change in the company's business operations or financial health. The stock price is not expected to be impacted by this specific regulatory compliance.